The Global Respiratory Care Devices market is estimated to reach $32.5 billion by 2024 from $21 billion in 2019; growing at a CAGR of 8.9% from 2019 to 2024.
Respiratory devices are used to supply respiratory gases to patients with impaired respiratory function. This respiratory gas is an oxygen-rich gas transported to the lungs with the help of respiratory devices.
The Global Respiratory Care Devices market is primarily driven by factors such as increasing population with respiratory diseases, increasing pollution, growing demand for the respiratory care devices, technological advancements are some of the major forces that drive the market.
The Global Respiratory Care Devices market is mainly classified based on the product, by indication, by end-user, and by region.
Based on the Product segment, the market is categorized into Therapeutic Devices (PAP Devices – Continuous Positive Airway Pressure Devices, Automatic PAP Devices, and Bi-Level PAP Devices), Ventilators (ICU Ventilators (High-end ICU Ventilators, Mid-end ICU Ventilators, Basic ICU Ventilators), Portable/Transportable ventilators), Nebulizers, Humidifiers (Heated Humidifiers, Passover Humidifiers), Oxygen Concentrators (Fixed Oxygen Concentrators, Portable Oxygen concentrators), Inhalers (Metered Dose Inhalers, Dry Powder Inhalers), Reusable Resuscitators (Adult Resuscitators, Infant/Neonatal resuscitators), Nitric Oxide Delivery Units, Oxygen Hoods, Monitoring Devices (Pulse Oximeters (Pulse oximeter sensors, Pulse oximeter equipment), Capnography, Gas Analyzers, Diagnostic Devices (Spirometers, Polysomnography Devices, Peak Flow Meters, Other Diagnostic Devices), Consumables & Accessories (Masks (Reusable Masks (Nasal Masks, Full-Face Masks, Nasal Pillow masks, Oral Masks), Disposable Mask), Disposable resuscitators, Breathing Circuits, Tracheostomy Tubes, Nasal Cannulas, Other Consumables & Accessories. Among them, the therapeutic devices segment dominated the market.
The indication is further segmented into Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Infectious Disease, Other diseases.
On the basis of the end-user, the market is further categorized into Hospitals, Ambulatory Care Centers, and Home Care Settings.
Based on geography, the global Respiratory Care Devices market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.
Among all the regions, North America generated the highest revenue and is likely to continue its dominance over the forecast period. The high growth in the region is attributed due to the presence of a large number of companies manufacturing the respiratory care devices, the occurrence of respiratory diseases, the increasing smoker population, and the increasing geriatric population.
Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Key players operating in the Respiratory Care Devices include Medtronic plc, Philips Healthcare, ResMed Inc., Masimo Corporation, Getinge AB, Fisher and Paykel Healthcare Co. Ltd., Air Liquide, Hamilton Medical AG, Invacare Corporation, Vyaire Medical, Chart Industries Inc., Drägerwerk AG & Co. KGaA
Respiratory Care Device Market Key Segments:
Table of Contents
Reason to Buy